Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic... Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2629 | 11.7366071429 | 2.24 | 2.61 | 2.16 | 22277 | 2.5239573 | CS |
| 4 | -0.5671 | -18.4723127036 | 3.07 | 3.2838 | 2.0202 | 50439 | 2.49086117 | CS |
| 12 | -0.5671 | -18.4723127036 | 3.07 | 7.31 | 2.0202 | 2446720 | 4.47507771 | CS |
| 26 | -1.1771 | -31.9864130435 | 3.68 | 7.31 | 2.0202 | 1539992 | 4.16372748 | CS |
| 52 | -3.3171 | -56.9948453608 | 5.82 | 12 | 2.0202 | 1689790 | 5.59887729 | CS |
| 156 | -53.6571 | -95.5432692308 | 56.16 | 61.76 | 2.0202 | 943677 | 8.74034688 | CS |
| 260 | -53.6571 | -95.5432692308 | 56.16 | 61.76 | 2.0202 | 943677 | 8.74034688 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
